These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10794110)

  • 1. The FDA approach to standardization and quality assurance of nucleic acid tests used to screen blood and plasma donations.
    Epstein JS; Hewlett IK
    Dev Biol (Basel); 2000; 102():223-7. PubMed ID: 10794110
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
    Pichl L; Heitmann A; Herzog P; Oster J; Smets H; Schottstedt V
    Transfusion; 2005 Jul; 45(7):1106-10. PubMed ID: 15987354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of West Nile virus in blood donations--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(32):769-72. PubMed ID: 12917583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of FDA licensed HIV assays using plasma from Cameroonian blood donors.
    Lee S; Hu J; Tang S; Wood O; Francis K; Machuca A; Rios M; Daniel S; Vockley C; Awazi B; Zekeng L; Hewlett I
    J Med Virol; 2006; 78 Suppl 1():S22-3. PubMed ID: 16622873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approves first viral-load test. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):94. PubMed ID: 11363657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid test system approval.
    AIDS Alert; 2002 Jan; 17(1):10. PubMed ID: 11862731
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical devices: immunology and microbiology devices: classification of in vitro human immunodeficiency virus drug resistance genotype assay. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(152):44380-2. PubMed ID: 17687800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA issues final guidance on nucleic acid tests.
    AIDS Alert; 2005 Apr; 20(4):46-7. PubMed ID: 15844224
    [No Abstract]   [Full Text] [Related]  

  • 9. For the proposition: for the diagnosis of viral infections, commercial assays provide more reliable results than do in-house assays.
    Gammie AJ
    Rev Med Virol; 2008; 18(2):73-6. PubMed ID: 18306442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FDA approves DNA test to measure hepatitis B virus levels.
    Lang L
    Gastroenterology; 2008 Nov; 135(5):1439-40. PubMed ID: 18848561
    [No Abstract]   [Full Text] [Related]  

  • 11. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA.
    Lucey C;
    Vox Sang; 2006 Nov; 91(4):331-5. PubMed ID: 17105609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Food and Drug Administration approves second West Nile virus screening test for donated blood and organs.
    Lang L
    Gastroenterology; 2007 Nov; 133(5):1402. PubMed ID: 17983794
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular oncodiagnostics: where we are and where we need to go.
    Liu ET
    J Clin Oncol; 2003 Jun; 21(11):2052-5. PubMed ID: 12775728
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical laboratory standardization in the European Community].
    Vives Corrons JL
    Sangre (Barc); 1993 Oct; 38(5):407-11. PubMed ID: 8140506
    [No Abstract]   [Full Text] [Related]  

  • 19. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of HIV-1 subtype RNA panels for the standardization of HIV-1 NAT assays.
    Lee S; Wood O; Taffs RE; Hu J; Machuca A; Vallejo A; Hewlett I
    J Virol Methods; 2006 Nov; 137(2):287-91. PubMed ID: 16920201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.